SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Targanta Therapeutics Corporation (TARG)

TARG RSS Feed
Add TARG Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 9/2/2017 10:12:38 PM - Followers: 0 - Board type: Free - Posts Today: 0

http://www.targanta.com/ http://finance.yahoo.com/q/ks?s=TARG Targanta Therapeutics' mission is to build a better antibiotic. The biopharmaceutical company is developing new treatments for severe, drug-resistant bacterial infections, including those that attack the skin, blood, and bone. Its lead candidate is oritavancin, which may treat both skin and blood infections; the drug was first discovered by Eli Lilly and further developed by InterMune, from whom Targanta acquired the rights in 2005. The company plans to develop other antibiotics in addition to oritavancin; it is working on one earlier-stage candidate that may fight osteomyelitis, an inflammation of the bone caused by infection. Targanta Therapeutics Corporation is a biopharmaceutical company focused on the development and commercialization of innovative antibiotics to treat serious infections in the hospital and other institutional settings. The Company is developing its lead antibiotic, oritavancin, for the treatment of serious gram-positive bacterial infections, including complicated skin and skin structure infections, or cSSSI, and bacteremia, a blood stream infection. Targanta expects to submit a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) in the first quarter of 2008 seeking to commercialize oritavancin for the treatment of cSSSI. Additionally, Targanta is developing a number of antibacterial agents currently in pre-clinical development. Targanta's strategy is to develop oritavancin into a leading therapy worldwide for the treatment of serious gram-positive infections, initially for the treatment of cSSSI and subsequently for other indications. Specifically, Targanta intends to: * Obtain regulatory approval for oritavancin for the treatment of cSSSI in the U.S.; * Build a hospital-directed sales force to commercialize oritavancin in the U.S.; * Pursue clinical development of oritavancin in other dosing regimens and for additional indications; * Submit a marketing authorization application (MAA) for oritavancin in the European Union and evaluate the potential for a blended commercialization strategy; * Out-license oritavancin to third parties for development and commercialization in key Asian countries; and * Pursue the development of other innovative antibiotics for the hospital market, either through in-licensing or internal development.
SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
TARG
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PostSubject
#24   so is 2012 the pay date? $6 maybe carldfw 09/02/17 10:12:38 PM
#23   Is anyone here in the lawsuit? carldfw 08/28/17 05:57:01 PM
#22   Let us know when you've find the others $$$-Play 01/13/09 11:08:41 AM
#21   Well done. Jim Bishop 01/13/09 10:15:56 AM
#20   Volume tells the story for many of these surf1944 01/13/09 10:15:08 AM
#19   Too bad, I had a feeling you might Jim Bishop 01/13/09 09:31:02 AM
#18   Jim nice news for TARG. Unfortunately, I findit 01/13/09 09:27:56 AM
#17   Volume will come into the stock now: surf1944 01/13/09 07:13:41 AM
#16   The Medicines Company to Acquire Targanta Therapeutics Jim Bishop 01/12/09 11:46:19 PM
#15   I am hedging on this one. Sold findit 01/07/09 01:21:52 PM
#14   I am waiting for the volume to come surf1944 01/07/09 01:05:27 PM
#13   Nice movement since last week. From around findit 01/07/09 12:59:04 PM
#12   Targanta Announces Corporate Restructuring surf1944 01/03/09 10:23:23 AM
#11   watch out today... Homard 12/05/08 09:49:38 AM
#10   Targanta's Oritavancin MAA Accepted for Review by EMEA surf1944 06/25/08 08:36:11 AM
#9   Targanta Completes Enrollment in Phase 2 Oritavancin Infrequent surf1944 05/23/08 10:27:08 AM
#8   Targanta Reports First-Quarter 2008 Financial Results surf1944 05/13/08 09:05:24 AM
#7   Targanta Announces Highlights of Oritavancin Data to Be surf1944 04/19/08 12:04:32 PM
#6   Targanta Announces FDA Acceptance of Oritavancin New Drug Application surf1944 04/09/08 08:33:03 AM
#5   Targanta Reports Fourth-Quarter and Full-Year 2007 Financial Results surf1944 03/24/08 08:00:41 AM
#4   Targanta Submits Oritavancin New Drug Application surf1944 02/11/08 08:30:46 AM
#3   Targanta to Participate in BIO CEO & Investor Conference surf1944 02/07/08 12:09:19 PM
#2   Targanta Reports Third-Quarter 2007 Financial Results surf1944 11/15/07 08:43:49 AM
#1   Targanta Therapeutics Announces Pricing of its Initial Public Offering surf1944 10/13/07 10:24:34 AM
PostSubject